Literature DB >> 19193676

Risk stratification of the patients with Brugada type electrocardiogram: a community-based prospective study.

Carla Giustetto1, Stefano Drago, Pier Giuseppe Demarchi, Paola Dalmasso, Francesca Bianchi, Andrea Sibona Masi, Paula Carvalho, Eraldo Occhetta, Guido Rossetti, Riccardo Riccardi, Roberta Bertona, Fiorenzo Gaita.   

Abstract

AIMS: Risk stratification of patients with Brugada electrocardiogram (ECG) is being strongly debated. Conflicting results have been suggested from international registries, which enrolled non-consecutive cases, studied with different programmed electrical stimulation (PES) protocols. The aim of this study was to prospectively evaluate the incidence of arrhythmic events and the prognostic role of clinical presentation, ECG, and of a standardized PES protocol in consecutive cases from a community-based population. METHODS AND
RESULTS: A total of 166 consecutive patients (45 +/- 14 years) with Brugada ECG were enrolled. Type 1 ECG was observed spontaneously in 72 (43%) and after pharmacological testing in 94 (57%). One hundred and three (62%) were asymptomatic, 58 (35%) had syncope, and five (3%) had a prior cardiac arrest. One hundred and thirty-five (81%) underwent PES with two extra stimuli up to ventricular refractoriness and 34% had ventricular fibrillation (VF) induced. Arrhythmic events occurred in nine patients at a mean follow-up of 30 +/- 21 months (2.2 events per 100 person-year): in three (60%) patients with aborted sudden death (aSD), five (8.6%) of those with syncope, and one (1%) of the asymptomatic. The only predictors of events were a history of syncope or aSD (P = 0.02) and induction at PES (P = 0.004).
CONCLUSION: Clinical presentation is the most important parameter in the risk stratification of patients with Brugada ECG. Programmed electrical stimulation seems valuable, particularly in patients with previous syncope.

Entities:  

Mesh:

Year:  2009        PMID: 19193676     DOI: 10.1093/europace/eup006

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  20 in total

Review 1.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

Review 2.  Electrocardiographic T Wave Abnormalities and the Risk of Sudden Cardiac Death: The Finnish Perspective.

Authors:  Jani T Tikkanen; Tuomas Kenttä; Kimmo Porthan; Heikki V Huikuri; M Juhani Junttila
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-09-22       Impact factor: 1.468

Review 3.  Brugada Syndrome:Risk Stratification And Management.

Authors:  Yoshifusa Aizawa
Journal:  J Atr Fibrillation       Date:  2016-10-31

Review 4.  Brugada Syndrome:Risk Stratification And Management.

Authors:  Konstantinos P Letsas; Stamatis Georgopoulos; Konstantinos Vlachos; Nikolaos Karamichalakis; Ioannis Liatakis; Panagiotis Korantzopoulos; Tong Liu; Michael Efremidis; Antonios Sideris
Journal:  J Atr Fibrillation       Date:  2016-08-31

Review 5.  Risk stratification in electrical cardiomyopathies.

Authors:  Christian Veltmann; Rainer Schimpf; Martin Borggrefe; Christian Wolpert
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

Review 6.  Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice.

Authors:  Yaniel Castro-Torres; Raimundo Carmona-Puerta; Richard E Katholi
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

Review 7.  Risk stratification and treatment of brugada syndrome.

Authors:  Elena Arbelo; Josep Brugada
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

Review 8.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200

9.  Cardiac events occurred commonly among apparently healthy Filipinos with the Brugada ECG pattern in the LIFECARE cohort.

Authors:  Giselle G Gervacio; Jaime Alfonso Manalo Aherrera; Rody G Sy; Lauro L Abrahan Iv; Michael Joseph Agbayani; Felix Eduardo Punzalan; Elmer Jasper B Llanes; Paul Ferdinand M Reganit; Olivia T Sison; E Shyong Tai; Felicidad V Velandria; Allan Gumatay; Nina T Castillo-Carandang
Journal:  Heart Asia       Date:  2018-05-17

10.  Quinidine: an "endangered species" drug appropriate for management of electrical storm in brugada syndrome.

Authors:  Stelios Paraskevaidis; Efstratios K Theofilogiannakos; Vasileios Kamperidis; Yiannis S Chatzizisis; Konstantinos Tsilonis; Vassilios P Vassilikos; George Dakos; George Stavropoulos; Antonios Ziakas; Stavros Hadjimiltiades; Ioannis H Styliadis
Journal:  Indian Pacing Electrophysiol J       Date:  2013-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.